{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:43:46Z","timestamp":1780479826811,"version":"3.54.1"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.maturitas.2016.07.018","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T17:38:49Z","timestamp":1469727529000},"page":"86-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Menopausal hormone therapy in cancer survivors: A narrative review of the literature"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5731-6159","authenticated-orcid":false,"given":"Carol L.","family":"Kuhle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Thielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminah","family":"Jatoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"Faubion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.maturitas.2016.07.018_bib0005","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0010","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/gme.0b013e31824bb039","article-title":"A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the women's health initiative","volume":"19","author":"Steinkellner","year":"2012","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jwh.2014.4746","article-title":"Competency in menopause management: whither goest the internist?","volume":"23","author":"Santen","year":"2014","journal-title":"J. Womens Health (Larchmt)"},{"key":"10.1016\/j.maturitas.2016.07.018_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4137\/CPath.S31563","article-title":"Diversity of breast carcinoma: histological subtypes and clinical relevance","volume":"8","author":"Makki","year":"2015","journal-title":"Clin. Med. Insights Pathol."},{"issue":"pt. A","key":"10.1016\/j.maturitas.2016.07.018_bib0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.steroids.2014.12.013","article-title":"Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers","volume":"99","author":"Brown","year":"2015","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0960-0760(00)00113-8","article-title":"Estrogens in the causation of breast, endometrial and ovarian cancers\u2014evidence and hypotheses from epidemiological findings","volume":"74","author":"Persson","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"9084","key":"10.1016\/j.maturitas.2016.07.018_bib0035","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer","volume":"350","author":"Cancer, C.G.o.H.F.i.B","year":"1997","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.maturitas.2016.07.018_bib0040","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's health initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"11","key":"10.1016\/j.maturitas.2016.07.018_bib0050","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/jc.2015-2236","article-title":"Treatment of symptoms of the menopause: an endocrine society clinical practice guideline","volume":"100","author":"Stuenkel","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0055","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/mol.111.072249","article-title":"The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor alpha and cyclin D1","volume":"80","author":"Lewis-Wambi","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.maturitas.2016.07.018_bib0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.maturitas.2016.07.018_bib0065","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1200\/JCO.2001.19.8.2357","article-title":"Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk","volume":"19","author":"Col","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.maturitas.2016.07.018_bib0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jama.1994.03520070060039","article-title":"Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group","volume":"72","author":"Cobleigh","year":"1994","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0075","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0002-9378(96)70594-X","article-title":"Hormone replacement therapy in breast cancer survivors: a cohort study","volume":"174","author":"DiSaia","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0080","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.1999.17.5.1482","article-title":"Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively","volume":"17","author":"Vassilopoulou-Sellin","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/gyno.1997.4621","article-title":"Estrogen replacement therapy in women with prior diagnosis and treatment for breast cancer","volume":"65","author":"Vassilopoulou-Sellin","year":"1997","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.maturitas.2016.07.018_bib0090","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnci\/93.10.754","article-title":"Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality","volume":"93","author":"O'Meara","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.maturitas.2016.07.018_bib0095","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"Holmberg","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0100","first-page":"322","article-title":"Hormone replacement therapy: an increased risk of recurrence and mortality for breast cancer patients?","volume":"6","author":"Lupo","year":"2015","journal-title":"J. Adv. Pract. Oncol."},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2012.07.003","article-title":"Hormone replacement therapy after breast cancer: 10year follow up of the Stockholm randomized trial","volume":"49","author":"Fahlen","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","article-title":"Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomized, non-inferiority trial","volume":"10","author":"Kenemans","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.maturitas.2016.07.018_bib0115","series-title":"World Cancer Report","article-title":"Lung cancer","author":"Brambilla","year":"2014"},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0120","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"19","key":"10.1016\/j.maturitas.2016.07.018_bib0125","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/jnci\/dji289","article-title":"Annual report to the nation on the status of cancer 1975\u20132002, featuring population-based trends in cancer treatment","volume":"97","author":"Edwards","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0130","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ijc.21078","article-title":"Statistical modeling and projections of lung cancer mortality in 4 industrialized countries","volume":"117","author":"Shibuya","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-5223(00)70213-3","article-title":"Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma","volume":"119","author":"de Perrot","year":"2000","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0145","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0003-4975(03)01024-5","article-title":"Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer","volume":"76","author":"Moore","year":"2003","journal-title":"Ann. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5761\/atcs.oa.10.01637","article-title":"Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis","volume":"17","author":"Nakamura","year":"2011","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/cancers4040969","article-title":"Estrogen signaling in lung cancer: an opportunity for novel therapy","volume":"4","author":"Baik","year":"2012","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.maturitas.2016.07.018_bib0160","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1210\/endo.138.11.5496","article-title":"Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse","volume":"138","author":"Couse","year":"1997","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.maturitas.2016.07.018_bib0165","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/pin.12326","article-title":"Estrogen and cancers of the colorectum, breast, and lung in postmenopausal women","volume":"65","author":"Honma","year":"2015","journal-title":"Pathol. Int."},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0170","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.seminoncol.2009.10.008","article-title":"Menopausal hormone therapy, hormone receptor status, and lung cancer in women","volume":"36","author":"Chlebowski","year":"2009","journal-title":"Semin. Oncol."},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1677\/ERC-08-0002","article-title":"Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma","volume":"15","author":"Hammoud","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"issue":"7","key":"10.1016\/j.maturitas.2016.07.018_bib0180","first-page":"2141","article-title":"Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen","volume":"62","author":"Stabile","year":"2002","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.lungcan.2014.05.019","article-title":"Serum estrogen receptor beta mediated bioactivity correlates with poor outcome in lung cancer patients","volume":"85","author":"Lim","year":"2014","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.lungcan.2011.03.009","article-title":"Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer","volume":"74","author":"Mah","year":"2011","journal-title":"Lung Cancer"},{"issue":"21","key":"10.1016\/j.maturitas.2016.07.018_bib0195","doi-asserted-by":"crossref","first-page":"10484","DOI":"10.1158\/0008-5472.CAN-07-2607","article-title":"Aromatase expression predicts survival in women with early-stage non small cell lung cancer","volume":"67","author":"Mah","year":"2007","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.maturitas.2016.07.018_bib0200","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1158\/0008-5472.CAN-04-3087","article-title":"Progesterone receptor in non-small cell lung cancer\u2014a potent prognostic factor and possible target for endocrine therapy","volume":"65","author":"Ishibashi","year":"2005","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/jwh.2009.1434","article-title":"Hormone therapy and risk of lung cancer: a meta-analysis","volume":"19","author":"Oh","year":"2010","journal-title":"J. Womens Health (Larchmt)"},{"issue":"8","key":"10.1016\/j.maturitas.2016.07.018_bib0210","doi-asserted-by":"crossref","first-page":"e71236","DOI":"10.1371\/journal.pone.0071236","article-title":"Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis","volume":"8","author":"Yao","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0215","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3961\/jpmph.15.054","article-title":"Hormonal replacement therapy and the risk of lung cancer in women: an adaptive meta-analysis of cohort studies","volume":"48","author":"Bae","year":"2015","journal-title":"J. Prev. Med. Public Health"},{"issue":"9697","key":"10.1016\/j.maturitas.2016.07.018_bib0220","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(09)61526-9","article-title":"Oestrogen plus progestin and lung cancer in postmenopausal women (women's health initiative trial): a post-hoc analysis of a randomized controlled trial","volume":"374","author":"Chlebowski","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cllc.2015.09.004","article-title":"Estrogen plus progestin and lung cancer: follow-up of the women's health initiative randomized trial","volume":"17","author":"Chlebowski","year":"2016","journal-title":"Clin. Lung Cancer"},{"issue":"18","key":"10.1016\/j.maturitas.2016.07.018_bib0230","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/jnci\/djq285","article-title":"Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial","volume":"102","author":"Chlebowski","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0235","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JTO.0000000000000077","article-title":"Survival in women with NSCLC: the role of reproductive history and hormone use","volume":"9","author":"Katcoff","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.maturitas.2016.07.018_bib0240","doi-asserted-by":"crossref","first-page":"e103735","DOI":"10.1371\/journal.pone.0103735","article-title":"Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California teachers study","volume":"9","author":"Clague","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1200\/JCO.2005.02.9827","article-title":"Hormone replacement therapy is associated with decreased survival in women with lung cancer","volume":"24","author":"Ganti","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0250","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"18","key":"10.1016\/j.maturitas.2016.07.018_bib0255","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa054967","article-title":"Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia","volume":"355","author":"Regula","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.maturitas.2016.07.018_bib0260","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1158\/1078-0432.CCR-09-0877","article-title":"Gender disparities in metastatic colorectal cancer survival","volume":"15","author":"Hendifar","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0265","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1572-0241.2007.01779.x","article-title":"Improved survival in young women with colorectal cancer","volume":"103","author":"Koo","year":"2008","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0270","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/bjs.4098","article-title":"Male gender adversely affects survival following surgery for colorectal cancer","volume":"90","author":"McArdle","year":"2003","journal-title":"Br. J. Surg."},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0275","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/carcin\/bgh346","article-title":"Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min\/+) mouse model of colorectal cancer","volume":"26","author":"Javid","year":"2005","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0280","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00384-012-1628-y","article-title":"Oestrogen and colorectal cancer: mechanisms and controversies","volume":"28","author":"Foster","year":"2013","journal-title":"Int. J. Colorectal Dis."},{"issue":"21","key":"10.1016\/j.maturitas.2016.07.018_bib0285","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1158\/1078-0432.CCR-13-0325","article-title":"Molecular pathways: estrogen pathway in colorectal cancer","volume":"19","author":"Barzi","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0290","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/PDM.0b013e3181656d67","article-title":"Expression of estrogen receptor beta in colon cancer progression","volume":"17","author":"Castiglione","year":"2008","journal-title":"Diagn. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0295","first-page":"17","article-title":"Loss of expression of estrogen receptor beta in colon cancer and its association with Dukes' staging","volume":"14","author":"Jassam","year":"2005","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.maturitas.2016.07.018_bib0300","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0959-8049(03)00239-9","article-title":"Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumor's dedifferentiation","volume":"39","author":"Konstantinopoulos","year":"2003","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.maturitas.2016.07.018_bib0305","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv210","article-title":"A prospective evaluation of endogenous sex hormone levels and colorectal cancer risk in postmenopausal women","volume":"107","author":"Murphy","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.maturitas.2016.07.018_bib0310","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/gutjnl-2011-300719","article-title":"Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women","volume":"61","author":"Limsui","year":"2012","journal-title":"Gut"},{"issue":"15","key":"10.1016\/j.maturitas.2016.07.018_bib0315","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1158\/0008-5472.CAN-06-4275","article-title":"Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women","volume":"67","author":"Newcomb","year":"2007","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0320","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0002-9343(99)00063-7","article-title":"Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis","volume":"106","author":"Grodstein","year":"1999","journal-title":"Am. J. Med."},{"issue":"5 pt. 2","key":"10.1016\/j.maturitas.2016.07.018_bib0325","first-page":"880","article-title":"Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis","volume":"93","author":"Nanda","year":"1999","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0330","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ijc.26026","article-title":"The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer","volume":"130","author":"Lin","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.maturitas.2016.07.018_bib0335","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/09513590600900378","article-title":"Colorectal cancer in middle-aged women in relation to hormonal status: a report from the women's health in the Lund Area (WHILA) study","volume":"22","author":"Nazeri","year":"2006","journal-title":"Gynecol. Endocrinol."},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0340","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/ijc.29878","article-title":"The influence of hormone therapies on type I and II endometrial cancer: a nationwide cohort study","volume":"138","author":"Morch","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.maturitas.2016.07.018_bib0345","unstructured":"Group, U.S.C.S.W., United States Cancer Statistics: 1999\u20132012 Incidence and Mortality Web-based Report, Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute, Atlanta, GA, 2015."},{"issue":"10","key":"10.1016\/j.maturitas.2016.07.018_bib0350","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa032071","article-title":"Estrogen plus progestin and colorectal cancer in postmenopausal women","volume":"350","author":"Chlebowski","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0355","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0360","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1158\/1055-9965.EPI-08-1209","article-title":"Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the women's health initiative clinical trial and observational study","volume":"18","author":"Prentice","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"32","key":"10.1016\/j.maturitas.2016.07.018_bib0365","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1200\/JCO.2012.42.7732","article-title":"Estrogen plus progestin and colorectal cancer incidence and mortality","volume":"30","author":"Simon","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.maturitas.2016.07.018_bib0370","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1055-9965.EPI-08-0385","article-title":"Conjugated equine estrogens and colorectal cancer incidence and survival: the women's health initiative randomized clinical trial","volume":"17","author":"Ritenbaugh","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"7","key":"10.1016\/j.maturitas.2016.07.018_bib0375","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jnci\/87.7.517","article-title":"Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women","volume":"87","author":"Calle","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0380","first-page":"467","article-title":"Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA)","volume":"10","author":"Slattery","year":"1999","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.maturitas.2016.07.018_bib0385","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/ijc.24248","article-title":"Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP diet and health study cohort","volume":"124","author":"Morton","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"36","key":"10.1016\/j.maturitas.2016.07.018_bib0390","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1200\/JCO.2006.08.0580","article-title":"Hormone replacement therapy and survival after colorectal cancer diagnosis","volume":"24","author":"Chan","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.maturitas.2016.07.018_bib0395","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood-2013-07-517292","article-title":"Inhibition of lymphoma vascularization and dissemination by estrogen receptor beta agonists","volume":"123","author":"Yakimchuk","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.maturitas.2016.07.018_bib0400","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/bjc.2013.507","article-title":"Exogenous hormone use, reproductive history and risk of adult myeloid leukemia","volume":"109","author":"Poynter","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.maturitas.2016.07.018_bib0405","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-065X.2000.imr017502.x","article-title":"Early B-lymphocyte precursors and their regulation by sex steroids","volume":"175","author":"Kincade","year":"2000","journal-title":"Immunol. Rev."},{"issue":"16","key":"10.1016\/j.maturitas.2016.07.018_bib0410","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1016\/j.yexcr.2008.07.015","article-title":"Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation","volume":"314","author":"Kauss","year":"2008","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0415","first-page":"1077","article-title":"Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia","volume":"5","author":"Li","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0420","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.critrevonc.2014.07.004","article-title":"Reproductive factors and non-Hodgkin lymphoma: a systematic review","volume":"92","author":"Costas","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0425","first-page":"483","article-title":"Hormone replacement therapy is not associated with an increased risk of leukemia (United States)","volume":"16","author":"Ross","year":"2005","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0430","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3109\/10428194.2012.722216","article-title":"Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort","volume":"54","author":"Teras","year":"2013","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0435","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/annonc\/mds340","article-title":"Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies","volume":"24","author":"Kane","year":"2013","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.maturitas.2016.07.018_bib0440","first-page":"1466","article-title":"Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia","volume":"11","author":"Cerhan","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0445","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/ijc.25730","article-title":"Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California teachers study","volume":"129","author":"Lu","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0450","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ijc.29819","article-title":"Menopausal estrogen therapy and non-Hodgkin's lymphoma: a post-hoc analysis of women's health initiative randomized clinical trial","volume":"138","author":"Kato","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0455","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.gme.0000232032.84788.8c","article-title":"Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review","volume":"14","author":"Tauchmanova","year":"2007","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0460","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","article-title":"Long-term health consequences of premature or early menopause and considerations for management","volume":"18","author":"Faubion","year":"2015","journal-title":"Climacteric"},{"issue":"8","key":"10.1016\/j.maturitas.2016.07.018_bib0465","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/00016340600677043","article-title":"Optimal treatment of premature ovarian failure after treatment for Hodgkin's lymphoma is often withheld","volume":"85","author":"Verschuuren","year":"2006","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"21","key":"10.1016\/j.maturitas.2016.07.018_bib0470","first-page":"591","article-title":"Vital signs: melanoma incidence and mortality trends and projections\u2014United States 1982\u20132030","volume":"64","author":"Guy","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.maturitas.2016.07.018_bib0475","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mce.2015.09.020","article-title":"Steroid hormone influence on melanomagenesis","volume":"417","author":"Mitkov","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0480","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archderm.1985.01660030072022","article-title":"A histopathologic evaluation of nevocellular nevi in pregnancy","volume":"121","author":"Foucar","year":"1985","journal-title":"Arch. Dermatol."},{"issue":"12","key":"10.1016\/j.maturitas.2016.07.018_bib0485","first-page":"1497","article-title":"Are melanocytic nevi influenced by pregnancy? A dermoscopic evaluation","volume":"32","author":"Zampino","year":"2006","journal-title":"Dermatol. Surg."},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0490","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000224736","article-title":"Is malignant melanoma an endocrine-dependent tumor? The possible adverse effect of estrogen","volume":"27","author":"Sadoff","year":"1973","journal-title":"Oncology"},{"issue":"8","key":"10.1016\/j.maturitas.2016.07.018_bib0495","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jamadermatol.2013.4408","article-title":"Melanoma survival disadvantage in young, non-Hispanic white males compared with females","volume":"149","author":"Gamba","year":"2013","journal-title":"JAMA Dermatol."},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0500","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2133.1991.tb04951.x","article-title":"Malignant melanoma occurring in those aged under 30 in the west of Scotland 1979\u20131986: a study of incidence, clinical features, pathological features and survival","volume":"124","author":"Mackie","year":"1991","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.maturitas.2016.07.018_bib0505","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/1097-0142(19820501)49:9<1941::AID-CNCR2820490932>3.0.CO;2-V","article-title":"The female superiority in survival in clinical stage II cutaneous malignant melanoma","volume":"49","author":"Shaw","year":"1982","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0510","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clindermatol.2010.04.003","article-title":"Do hormones influence melanoma? Facts and controversies","volume":"28","author":"Gupta","year":"2010","journal-title":"Clin. Dermatol."},{"issue":"7","key":"10.1016\/j.maturitas.2016.07.018_bib0515","doi-asserted-by":"crossref","first-page":"e0134396","DOI":"10.1371\/journal.pone.0134396","article-title":"Estrogen receptor beta agonists differentially affect the growth of human melanoma cell lines","volume":"10","author":"Marzagalli","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.maturitas.2016.07.018_bib0520","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrc3093","article-title":"The different roles of ER subtypes in cancer biology and therapy","volume":"11","author":"Thomas","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0525","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1586\/era.11.42","article-title":"Estrogens, estrogen receptors and melanoma","volume":"11","author":"de Giorgi","year":"2011","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0530","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/bjd.12056","article-title":"Oestrogen receptor beta and melanoma: a comparative study","volume":"168","author":"de Giorgi","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0535","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/bjc.1985.275","article-title":"Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada melanoma study","volume":"52","author":"Gallagher","year":"1985","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0540","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/annonc\/mdn589","article-title":"Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study","volume":"20","author":"Koomen","year":"2009","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0545","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/aje\/kwk040","article-title":"Reproductive risk factors for cutaneous melanoma in women: a case-control study","volume":"165","author":"Lea","year":"2007","journal-title":"Am. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.maturitas.2016.07.018_bib0550","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.annepidem.2004.10.005","article-title":"Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy","volume":"15","author":"Naldi","year":"2005","journal-title":"Ann. Epidemiol."},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0555","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ijc.2910420603","article-title":"The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women","volume":"42","author":"Osterlind","year":"1988","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0560","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T","article-title":"Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy\u2014long-term follow-up of a Swedish cohort","volume":"67","author":"Persson","year":"1996","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0565","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/ije\/27.5.751","article-title":"Hormonal and reproductive influences and risk of melanoma in women","volume":"27","author":"Smith","year":"1998","journal-title":"Int. J. Epidemiol."},{"issue":"17","key":"10.1016\/j.maturitas.2016.07.018_bib0570","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.ejca.2011.04.023","article-title":"Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis","volume":"47","author":"Gandini","year":"2011","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.maturitas.2016.07.018_bib0575","first-page":"661","article-title":"Cutaneous melanoma in women: ovulatory life, menopause, and use of exogenous estrogens","volume":"3","author":"Holly","year":"1994","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0580","first-page":"827","article-title":"Cutaneous melanoma in relation to exogenous hormones and reproductive factors","volume":"70","author":"Holly","year":"1983","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0585","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/sj.bjc.6601595","article-title":"Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma","volume":"90","author":"MacKie","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0590","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.maturitas.2009.11.017","article-title":"Hormone replacement after gynaecological cancer","volume":"65","author":"Singh","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2016.07.018_bib0595","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.steroids.2014.06.001","article-title":"Menopausal hormone therapy and cancer: changing clinical observations of target site specificity","volume":"90","author":"Chlebowski","year":"2014","journal-title":"Steroids"},{"issue":"12","key":"10.1016\/j.maturitas.2016.07.018_bib0600","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/aje\/kwq300","article-title":"Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European prospective investigation into cancer and nutrition","volume":"172","author":"Allen","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"9470","key":"10.1016\/j.maturitas.2016.07.018_bib0605","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone-replacement therapy in the million women study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0610","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.24672","article-title":"Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the nurses' health study cohort 1976\u20132004","volume":"126","author":"Karageorgi","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"16","key":"10.1016\/j.maturitas.2016.07.018_bib0615","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.ejca.2007.08.014","article-title":"Prognostic significance of estrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas","volume":"43","author":"Shabani","year":"2007","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0620","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0360-3016(89)90365-9","article-title":"The predictive value of progesterone receptor levels in endometrial cancer","volume":"17","author":"Ingram","year":"1989","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.maturitas.2016.07.018_bib0625","unstructured":"Institute, N.C., Endometrial cancer treatment-for health professionals. http:\/\/www.cancer.gov\/types\/uterine\/hp\/endometrial-treatment-pdq (accessed 7.02.16)."},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0630","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0002-9378(96)70027-3","article-title":"Estrogen replacement in surgical stage I and II endometrial cancer survivors","volume":"175","author":"Chapman","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0635","first-page":"326","article-title":"Estrogen replacement therapy in the patient treated for endometrial cancer","volume":"67","author":"Creasman","year":"1986","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0640","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0090-8258(90)90171-G","article-title":"Estrogen replacement therapy following treatment for stage I endometrial carcinoma","volume":"36","author":"Lee","year":"1990","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0645","first-page":"555","article-title":"Estrogen replacement therapy in endometrial cancer patients: a matched control study","volume":"97","author":"Suriano","year":"2001","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0650","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/ijgc-00009577-200603000-00054","article-title":"Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors?","volume":"16","author":"Ayhan","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0655","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a gynecologic oncology group study","volume":"24","author":"Barakat","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.maturitas.2016.07.018_bib0660","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2014.03.006","article-title":"Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis","volume":"50","author":"Shim","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.maturitas.2016.07.018_bib0665","unstructured":"Surveillance, E., and End Results Program (SEER), SEER cancer statistics factsheets: Ovary cancer. http:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html (accessed 1.11.15)."},{"issue":"19","key":"10.1016\/j.maturitas.2016.07.018_bib0670","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1200\/JCO.2006.08.4590","article-title":"Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a gynecologic oncology group study","volume":"25","author":"Gershenson","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0020-7292(96)02719-1","article-title":"Diagnosis and management of malignant germ cell ovarian tumors in young females","volume":"55","author":"Zalel","year":"1996","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0680","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3802\/jgo.2015.26.4.343","article-title":"Controversies in borderline ovarian tumors","volume":"26","author":"Seong","year":"2015","journal-title":"J. Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.maturitas.2016.07.018_bib0685","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1470-2045(12)70075-X","article-title":"Conjugated equine estrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the women's health initiative randomized placebo-controlled trial","volume":"13","author":"Anderson","year":"2012","journal-title":"Lancet Oncol."},{"issue":"9980","key":"10.1016\/j.maturitas.2016.07.018_bib0690","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"385","author":"Beral","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0695","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.maturitas.2015.02.011","article-title":"Menopausal hormone therapy and ovarian cancer: putting risk into perspective","volume":"81","author":"Perez-Lopez","year":"2015","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0700","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/13697137.2015.1023615","article-title":"A commentary on a recent update of the ovarian cancer risk attributable to menopausal hormone therapy","volume":"18","author":"Gompel","year":"2015","journal-title":"Climacteric"},{"issue":"9","key":"10.1016\/j.maturitas.2016.07.018_bib0705","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.0001-6349.2004.00550.x","article-title":"Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies","volume":"83","author":"Riman","year":"2004","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"12","key":"10.1016\/j.maturitas.2016.07.018_bib0710","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/ijc.22218","article-title":"Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival","volume":"119","author":"Mascarenhas","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0715","first-page":"231","article-title":"Clinicopathologic review of 118 granulosa and 82 theca cell tumors","volume":"55","author":"Evans","year":"1980","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0720","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"6771","key":"10.1016\/j.maturitas.2016.07.018_bib0725","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bmj.302.6771.259","article-title":"Hormone replacement therapy and survival after surgery for ovarian cancer","volume":"302","author":"Eeles","year":"1991","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0730","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00042192-200101000-00012","article-title":"Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival","volume":"8","author":"Ursic-Vrscaj","year":"2001","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0735","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3109\/13697137.2013.806472","article-title":"The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China","volume":"16","author":"Wen","year":"2013","journal-title":"Climacteric"},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0740","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1013::AID-CNCR17>3.0.CO;2-1","article-title":"Estrogen replacement therapy for ovarian carcinoma survivors: a randomized controlled trial","volume":"86","author":"Guidozzi","year":"1999","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0745","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2015.07.109","article-title":"Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis","volume":"139","author":"Li","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"35","key":"10.1016\/j.maturitas.2016.07.018_bib0750","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1200\/JCO.2015.60.9719","article-title":"Adjuvant hormone therapy may improve survival in epithelial ovarian cancer: results of the AHT randomized trial","volume":"33","author":"Eeles","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.maturitas.2016.07.018_bib0755","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/bjc.2015.377","article-title":"Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study","volume":"113","author":"Besevic","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0760","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/GME.0000000000000508","article-title":"Hormone therapy for ovarian cancer survivors: systematic review and meta-analysis","volume":"23","author":"Pergialiotis","year":"2016","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0765","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.22357","article-title":"Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8097 women with squamous cell carcinoma and 1374 women with adenocarcinoma from 12 epidemiological studies","volume":"120","author":"Cancer, I.C.o.E.S.o.C","year":"2007","journal-title":"Int. J. Cancer."},{"issue":"4","key":"10.1016\/j.maturitas.2016.07.018_bib0770","first-page":"1341","article-title":"Oestrogen and progesterone receptor expression in patients with adenocarcinoma of the uterine cervix and correlation with various clinicopathological parameters","volume":"30","author":"Bodner","year":"2010","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.maturitas.2016.07.018_bib0775","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0090-8258(86)90134-4","article-title":"The influence of estrogen and progesterone receptors on survival in patients with carcinoma of the uterine cervix","volume":"23","author":"Martin","year":"1986","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0780","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3109\/13697130903075352","article-title":"Risk of gynaecological cancers in users of estradiol\/dydrogesterone or other HRT preparations","volume":"12","author":"Schneider","year":"2009","journal-title":"Climacteric"},{"issue":"7100","key":"10.1016\/j.maturitas.2016.07.018_bib0785","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/bmj.315.7100.85","article-title":"Case-control study of estrogen replacement therapy and risk of cervical cancer","volume":"315","author":"Parazzini","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.maturitas.2016.07.018_bib0790","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/gyno.2000.5731","article-title":"Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix","volume":"77","author":"Lacey","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"9312","key":"10.1016\/j.maturitas.2016.07.018_bib0795","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"issue":"9364","key":"10.1016\/j.maturitas.2016.07.018_bib0800","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","article-title":"Cervical cancer and use of hormonal contraceptives: a systematic review","volume":"361","author":"Smith","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.maturitas.2016.07.018_bib0805","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0090-8258(87)90270-8","article-title":"Hormonal replacement therapy in patients after cervical cancer treatment","volume":"26","author":"Ploch","year":"1987","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.maturitas.2016.07.018_bib0810","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/GME.0000000000000357","article-title":"Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study","volume":"22","author":"Everhov","year":"2015","journal-title":"Menopause"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512216301803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512216301803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:08:09Z","timestamp":1759914489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512216301803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":162,"alternative-id":["S0378512216301803"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2016.07.018","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menopausal hormone therapy in cancer survivors: A narrative review of the literature","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2016.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}